Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- 1 October 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 33 (8) , 848-858
Abstract
Induction of cytotoxic CD8 T-cell responses is enhanced by the exclusive presentation of antigen through dendritic cells, and by innate stimuli, such as toll-like receptor ligands. On the basis of these 2 principles, we designed a vaccine against melanoma. Specifically, we linked the melanoma-specific Melan-A/Mart-1 peptide to virus-like nanoparticles loaded with A-type CpG, a ligand for toll-like receptor 9. Melan-A/Mart-1 peptide was cross-presented, as shown in vitro with human dendritic cells and in HLA-A2 transgenic mice. A phase I/II study in stage II-IV melanoma patients showed that the vaccine was well tolerated, and that 14/22 patients generated ex vivo detectable T-cell responses, with in part multifunctional T cells capable to degranulate and produce IFN-γ, TNF-α, and IL-2. No significant influence of the route of immunization (subcutaneous versus intradermal) nor dosing regimen (weekly versus daily clusters) could be observed. It is interesting to note that, relatively large fractions of responding specific T cells exhibited a central memory phenotype, more than what is achieved by other nonlive vaccines. We conclude that vaccination with CpG loaded virus-like nanoparticles is associated with a human CD8 T-cell response with properties of a potential long-term immune protection from the disease.Keywords
This publication has 31 references indexed in Scilit:
- Nanoparticles target distinct dendritic cell populations according to their sizeEuropean Journal of Immunology, 2008
- Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigenProceedings of the National Academy of Sciences, 2008
- Protective ‘immunity’ by pre‐existent neutralizing antibody titers and preactivated T cells but not by so‐called ‘immunological memory’Immunological Reviews, 2006
- Long‐lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activationEuropean Journal of Immunology, 2006
- Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus diseaseJournal of Experimental Medicine, 2005
- Ex Vivo Analysis of Human Antigen-Specific CD8+ T-Cell Responses: Quality Assessment of Fluorescent HLA-A2 Multimer and Interferon-γ ELISPOT Assays for Patient Immune MonitoringJournal of Immunotherapy, 2004
- A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responsesVaccine, 2002
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distributionMelanoma Research, 1998
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.Journal of Experimental Medicine, 1994